Editorial

We are pleased to introduce you to 7th edition of the Critical Care Clinical Trialists (3CT) Workshop, which will take place on June 26 & 27, 2025, at the Embassy of France in Washington, DC.

The 3CT Workshop aims to foster an international exchange of ideas where attendees will brainstorm on trial design, conduct, ethics and data interpretation in the critical care area. The sessions will cover domains including drugs, devices, and biomarkers in the field of intensive care.

Following the template of the CVCT workshop, the Critical Care Clinical Trialists (3CT) workshop is a high-level think-tank, with an exceptional expert faculty. It involves a limited number of attendees and includes distinguished intensivists, pulmonologists, cardiologists, emergency physicians, clinical trialists, principal investigators and statisticians from academia, R&D pharma, NIH, EMA, FDA and PMDA.

I am pleased to announce that for the fifth year running, the proceedings from last year’s Workshop have been accepted for publication in a world leading medical journal.

I, along with my co-chairs, Sean Collins (Nashville, USA), Michael Matthay (San Francisco, United States), Michelle Chew (Linköping, Sweden), Naoki Sato (Tokyo, Japan) and Susanna Price (London, United Kingdom), look forward to welcoming you back in Washington D.C.

With my best wishes,

Professor Alexandre MEBAZAA
Lariboisière Hospital - University of Paris-Cité
INSERM Unit 942 Mascot
Paris, France